Human recombinant interleukin-2 as an experimental therapeutic.
Department of Pharmacology, Cetus Corporation, Emeryville, California 94608.
J L
JL
Winkelhake
S S
SS
Gauny
D000818:Animals; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity
D007376:Interleukin-2; D011994:Recombinant Proteins